Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 28

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 28
---
    ●
    our diligence obligations under license agreements and what activities satisfy those diligence obligations; 

    ●
    the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us; and

    ●
    the priority of invention of patented technology.

In addition, the agreements under
which we currently license intellectual property or technology from third parties are complex, and certain provisions in such agreements
may be susceptible to multiple interpretations.

The resolution of any contract
interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property
or technology or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could
have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over
intellectual property that we have licensed prevent or impair our ability to maintain our licensing arrangements on commercially acceptable
terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a material adverse
effect on our business, financial condition, results of operations, and prospects.

If we do not obtain required intellectual property
licenses or rights, we could encounter delays in our product development efforts while we attempt to design around other patents or even
be prohibited from developing, manufacturing or selling products requiring these rights or licenses. There is also a risk that legal disputes
may arise as to the rights to technology developed in collaboration with other parties, all with attendant risk, distraction, expense,
and lack of predictability.

If we are unable to obtain
and maintain sufficient intellectual property protection for our product candidates, or if the scope of the intellectual property protection
is not sufficiently broad, our ability to commercialize our product candidates successfully and to compete effectively may be adversely
affected.

We rely upon a combination of
patents, trademarks, trade secrets and confidentiality agreements – either that we own or possess or that are owned or possessed
by our licensors that are licensed to us – to protect the intellectual property related to our technology and product candidates.
When we refer to “our” technologies, inventions, patents, provisional patents, patent applications or other intellectual property
rights, we are referring to both the rights that we own or possess as well as those that we license, many of which are critical to our
intellectual property protection and our business. For example, the product candidates and platform technology we have licensed from our
licensors are protected primarily by patent